Low-dose growth hormone inhibits 11 beta-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity.
GH has potent effects on adipocyte biology, stimulating lipolysis but also promoting preadipocyte proliferation. In addition, GH, acting through IGF-I, inhibits 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1), which converts the inactive glucocorticoid, cortisone (E), to active cortisol (...
Principais autores: | Tomlinson, J, Crabtree, N, Clark, P, Holder, G, Toogood, A, Shackleton, C, Stewart, P |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2003
|
Registros relacionados
-
Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
por: Tomlinson, J, et al.
Publicado em: (2001) -
Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.
por: Tomlinson, J, et al.
Publicado em: (2004) -
Cortisol, 11 beta-hydroxysteroid dehydrogenase type 1 and central obesity.
por: Stewart, P, et al.
Publicado em: (2002) -
The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.
por: Tomlinson, J, et al.
Publicado em: (2002) -
The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis.
por: Tomlinson, J, et al.
Publicado em: (2000)